GT Biopharma Reports Third Quarter 2026 Financial Results
Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026 Phas
Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026 Phas